A
Allen D. Sawitzke
Researcher at University of Utah
Publications - 54
Citations - 3477
Allen D. Sawitzke is an academic researcher from University of Utah. The author has contributed to research in topics: Arthritis & Osteoarthritis. The author has an hindex of 25, co-authored 53 publications receiving 3150 citations.
Papers
More filters
Journal ArticleDOI
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
Daniel O. Clegg,Domenic J. Reda,Crystal L. Harris,Marguerite A. Klein,James R. O'Dell,Michele Hooper,John D. Bradley,Clifton O. Bingham,Michael H. Weisman,Christopher G. Jackson,Nancy E Lane,John J. Cush,Larry W. Moreland,H. Ralph Schumacher,Chester V. Oddis,Frederick Wolfe,Jerry A. Molitor,David E. Yocum,Thomas J. Schnitzer,Daniel E. Furst,Allen D. Sawitzke,Helen Shi,Kenneth D. Brandt,Roland W. Moskowitz,H. James Williams +24 more
TL;DR: The GAIT trial as discussed by the authors evaluated the efficacy and safety of glucosamine and chondroitin sulfate as a treatment for knee pain from osteoarthritis in 1583 patients.
Journal ArticleDOI
Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study
Jill P. Buyon,Mimi Y. Kim,Marta M. Guerra,Carl A. Laskin,Michelle Petri,Michael D. Lockshin,Lisa R. Sammaritano,D. Ware Branch,T. Flint Porter,Allen D. Sawitzke,Joan T. Merrill,Mary D. Stephenson,Elisabeth Cohn,Lamya Garabet,Jane E. Salmon +14 more
TL;DR: In this paper, since systemic lupus erythematosus (SLE) affects women of reproductive age, pregnancy is a major concern, and pregnancy is the most common cause of SLE related deaths.
Journal ArticleDOI
The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: A report from the glucosamine/chondroitin arthritis intervention trial
Allen D. Sawitzke,Helen Shi,Martha F. Finco,Dorothy D. Dunlop,Clifton O. Bingham,Crystal L. Harris,Nora G. Singer,John D. Bradley,David S. Silver,Christopher G. Jackson,Nancy E Lane,Chester V. Oddis,Frederick Wolfe,Jeffrey R. Lisse,Daniel E. Furst,Domenic J. Reda,Roland W. Moskowitz,H. James Williams,Daniel O. Clegg +18 more
TL;DR: At 2 years, no treatment achieved a predefined threshold of clinically important difference in JSW loss as compared with placebo, however, knees with K/L grade 2 radiographic OA appeared to have the greatest potential for modification by these treatments.
Journal ArticleDOI
Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT
Allen D. Sawitzke,Helen Shi,Martha F. Finco,Dorothy D. Dunlop,Crystal L. Harris,Nora G. Singer,John D. Bradley,David S. Silver,Christopher G. Jackson,Nancy E Lane,Chester V. Oddis,Frederick Wolfe,Jeffrey R. Lisse,Daniel E. Furst,Clifton O. Bingham,Domenic J. Reda,Roland W. Moskowitz,H. James Williams,Daniel O. Clegg +18 more
TL;DR: Over 2 years, no treatment achieved a clinically important difference in WOMAC pain or function as compared with placebo, however, glucosamine and celecoxib showed beneficial but not significant trends.
Journal ArticleDOI
Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib
Marc C. Hochberg,Johanne Martel-Pelletier,Jordi Monfort,Ingrid Möller,Castillo,Nigel K Arden,Nigel K Arden,Nigel K Arden,Francis Berenbaum,Francisco J. Blanco,Philip G. Conaghan,Gema Domenech,Yves Henrotin,Thomas Pap,Pascal Richette,Allen D. Sawitzke,Patrick du Souich,Jean-Pierre Pelletier +17 more
TL;DR: CS+GH has comparable efficacy to celecoxib in reducing pain, stiffness, functional limitation and joint swelling/effusion after 6 months in patients with painful knee osteoarthritis, with a good safety profile.